Literature DB >> 22373818

A poly(L-lysine)-based hydrophilic star block co-polymer as a protein nanocarrier with facile encapsulation and pH-responsive release.

Yunsong Yan1, Daixu Wei, Jiayan Li, Jinhong Zheng, Ganggang Shi, Wenhong Luo, Ying Pan, Jinzhi Wang, Lumian Zhang, Xiaoying He, Daojun Liu.   

Abstract

A hydrophilic star block co-polymer was synthesized, characterized, and evaluated as a protein nanocarrier. The star block co-polymer was composed of a hyperbranched polyethylenimine (PEI) core, a poly(L-lysine) (PLL) inner shell, and a poly(ethylene glycol) (PEG) outer shell. The model protein insulin can be rapidly and efficiently encapsulated by the synthesized polymer in aqueous phosphate buffer at physiological pH. Complexation between PEI-PLL-b-PEG and insulin was investigated using native polyacrylamide gel electrophoresis. The uptake of enhanced green fluorescent protein into Ad293 cells mediated by PEI-PLL-b-PEG was also investigated. The encapsulated insulin demonstrated sustained release at physiological pH and showed accelerated release when the pH was decreased. The insulin released from the star block co-polymer retained its chemical integrity and immunogenicity.
Copyright © 2012 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22373818     DOI: 10.1016/j.actbio.2012.02.016

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  2 in total

1.  Development of a nanomedicine-loaded hydrogel for sustained delivery of an angiogenic growth factor to the ischaemic myocardium.

Authors:  Joanne O'Dwyer; Robert Murphy; Eimear B Dolan; Lenka Kovarova; Martin Pravda; Vladimir Velebny; Andreas Heise; Garry P Duffy; Sally Ann Cryan
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

2.  Poly(Ethylene Glycol) Crosslinked Multi-Armed Poly(l-Lysine) with Encapsulating Capacity and Antimicrobial Activity for the Potential Treatment of Infection-Involved Multifactorial Diseases.

Authors:  Chao Lu; Ting Wen; Maochao Zheng; Daojun Liu; Guilan Quan; Xin Pan; Chuanbin Wu
Journal:  Pharmaceutics       Date:  2020-01-06       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.